Vaccine developers at the testing phase now are seeking developing countries where vaccination rates remain low and the virus is still active.
For Kanoko Matsuyama's latest contributions to The Japan Times, see below:
Japanese officials have requested further restrictions on activities inside and outside a U.S. military base in Okinawa Prefecture in order to alleviate the anxiety of local residents.
Some COVID-19 patients get a hotel booking — and can enroll in clinical trials during their stay — with their positive test results.
Two years into the pandemic, the emergence of yet another COVID-19 variant means the world will need to find long-term strategies to coexist with delta, omicron and the strains to come.
The proportion of people sleeping less than the recommended eight hours is rising globally, and costs Japan as much as $138 billion in economic losses each year, according to Rand Corp.
Balmuda, best known for its stylish but expensive toaster, is hoping to bring its know-how to the ultra-competitive smartphone market.
The country this week pushed ahead of Canada, which previously had the highest rate among the G7 major advanced economies.
A class of drugs is emerging that can attack cancer cells in the body without damaging surrounding healthy ones. They have the potential to replace chemotherapy and its disruptive side effects, reshaping the future of cancer care. The complex biological medicines, called antibody drug conjugates ...
Nobel Prize winner Koichi Tanaka says the predictive blood test for Alzheimer's disease he and colleagues spent almost a decade developing is a double-edged sword. Without medications to stave off the memory-robbing condition, identifying those at risk will do nothing to ease the dementia burden ...
Selling painkillers in Japan used to be like pulling teeth. That was until baby boomers discovered how analgesics could take the sting from arthritis, diabetic nerve damage and the ravages of cancer. Now demand is taking off and drugmakers are introducing new products to a ...